Scientific notes

Immune Check Point Modulator in Cancer Therapy

Immune Checkpoint Modulators

Summary

 Immune Checkpoint modulators are new promising therapies that specifically target the ability of tumors to become “invisible” to the patient immune systems. Several proteins are involved in this mechanism, the below video will highlight the main ones and their role in the immune response

Discover our Check Point modulator validation system — Save biopsies, improve result quality and reduce false positive and negative

Related Posts

Poster cover with Gustave Roussy and Cherry Biotech logos, title ‘Development of a 3D immunocompetent breast cancer model to accelerate drug testing and personalised medicine,’ authors listed, and four fluorescent microscopy images of circular tumor spheroids with red/yellow immune-cell staining on a blue gradient background.
Scientific Poster – Development of a 3D immunocompetent breast ...
Authors: Priyanka Fernandes, Harry Dawson, Ethan N.P Vong, Pierre Savagner, Dario Fassini   Breast cancer remains one of the leading causes...
Read more
Immuno-oncology Trial Endpoints: Capturing Meaningful Activity...
Introduction In this paper, Anagnostou and colleagues “discuss endpoints used in I-O trials to date and potential optimal endpoints for f...
Read more
Organs-on-chip-ShantiA-2018
In Vitro Immune Organs-on-Chip for Drug Development...
Organs-on-Chip for Drug Development A drug should pass the preclinical evaluation phase to be FDA-approved. This relies (i) on in vitro cel...
Read more

get in touch

Get the best insights about Cherry Biotech by Email Let’s stay in touch!
As part of our commercial prospecting, we may need to process your personal data. For more information, please consult our Privacy Policy
×

Our Associated Solutions

Banner

Need to generate real life like preclinical data with complex biological models?

Discover Cubix - Platform and Service
×

Contact Us!

Aside

We're happy to answer any questions you may have. Reach out to our team for assistance.

Contact Now